Ki:elements pioneers speech-based biomarkers as tools for clinical research. We are seeking a strategic and commercially minded Therapeutic Area Lead to guide the development, positioning, and market success of SB-C, our speech biomarker for cognition.
This role combines product ownership with commercial leadership — shaping the vision, driving adoption, and acting as the trusted external champion of SB-C across the Alzheimer’s disease and cognitive health ecosystem.
You will own the end-to-end strategy for SB-C: from defining the product roadmap and market fit to leading external engagement with pharma and biotech partners. You will be the bridge between science, product, and business — ensuring SB-C continues to advance as the industry’s most trusted digital cognitive assessment.
Tasks
* Define and own the strategic vision and roadmap for SB-C within Alzheimer’s disease and related cognitive disorders.
* Work closely with R&D, data science, clinical, and regulatory teams to align technical development with customer and market needs.
* Translate market insights and clinical developments into product requirements and value propositions.
* Guide evidence-generation and validation strategies to strengthen product credibility and differentiation.
* Act as the primary commercial champion for SB-C — representing the product externally with clients, partners, and industry bodies.
* Build and manage strategic partnerships with pharma, biotech, CROs, and digital health collaborators deploying SB-C.
* Lead go-to-market planning, pricing strategy, and client engagement approaches.
* Support business development by articulating the clinical and commercial value of SB-C to prospective partners.
* Monitor competitive landscape and market trends in AD and digital biomarkers to identify growth opportunities.
* Serve as a trusted expert in cognition and Alzheimer’s disease, supporting client implementation and ensuring scientific credibility.
* Collaborate cross-functionally across the organization to drive alignment and impact.
* Represent SB-C at key scientific and industry events, publications, and collaborations.
Requirements
* Advanced degree in neuroscience, psychology, pharmacology, or a related field; MBA or equivalent commercial experience is an asset.
* Between 5 and 15 years of expertise in Alzheimer’s disease drug development, cognitive assessment, or biomarker strategy, ideally with product or commercial exposure.
* Deep understanding of cognition, clinical endpoints, and the evolving biomarker landscape in neurodegenerative diseases.
* Strategic thinker with strong commercial acumen.
* Excellent communication and relationship-building skills.
* Comfortable operating at the interface of science and business.
* Experience engaging pharma or biotech partners is highly desirable.
* Up to 30% travel.
Benefits
* ki:elements offers a four-day workweek (100% = 32 hours; Mo-Th)
* Remote (Europe & US East Coast preferred) or at our offices in Berlin & Saarbrücken.
* Be part of a pioneering company at the forefront of healthcare innovation.
* Work with a talented and passionate team dedicated to making a difference.
* 85.000€ - 120.000€ in full time (100%); part-time equivalent.
If our profiles match, we would be delighted to hear from you. Please contact us with your resume and a brief note why we should work together in the future.